Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
HKPD
↓ PDF (Pro)Cellyan Biotechnology Co. Ltd Class A Ordinary Shares
HealthcareMedical DistributionHong KongNASDAQ
$0.57
-14.84%today
MKT CAP
$13M
-9.5% · 1Y
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership62.3%
Institutional Ownership0.4%
Short % of Float0.01%
Days to Cover0.0d
1 Week-1.5%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Stonex Group Inc. | institution | 0.39% | $0.00B | +100.00% | 2025-12-31 |
| Two Sigma Investments, LP | institution | 0.15% | $0.00B | +100.00% | 2025-12-31 |
| Clear Street Group Inc. | institution | 0.11% | $0.00B | +0.00% | 2025-12-31 |
| UBS Group AG | institution | 0.01% | $0.00B | +1467.35% | 2025-12-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for HKPD.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.